Skip to main content
The Name of the #1 Stock to Trade in 2021
Expert Jeff Clark is releasing his #1 stock to trade in 2021.

Since he started recommending this stock, you could have used it for gains as high as 269% and even 273%... in as little as 8 days.
Click here now and get its name.

ONCS Insider Trading (OncoSec Medical)

Insider Ownership Percentage: 0.71%
Insider Buying (Last 12 Months): $35,798,182.35
Insider Selling (Last 12 Months): $737,156.29

OncoSec Medical Insider Trading History Chart

OncoSec Medical Share Price & Price History

$4.02
▼ -0.07 (-1.71%)
As of 05/7/2021 01:00 AM ET
Days: 30 | 90 | 365
Free Report: 3 Cryptos to Beat Bitcoin
The Coinbase IPO was one of the biggest technology IPOs in history. Experts believe it could kick-start a massive wave of cryptocurrency investing…

Certain tokens could see their value shoot through the roof!

Matt McCall – one of America’s top crypto analysts – just named 3 tokens he believes folks should own in the wake of the Coinbase IPO.
Just click here to claim your free report today.
pixel

OncoSec Medical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/3/2021Robert J DelaversanoVPSell453$4.86$2,201.5824,980View SEC Filing Icon  
4/30/2021Daniel J O'connorCEOSell3,172$4.86$15,415.9296,097View SEC Filing Icon  
4/16/2021Grand Pharmaceutical & H ChinaMajor ShareholderBuy1,691,806$3.45$5,836,730.70View SEC Filing Icon  
2/1/2021Daniel J O'connorCEOSell3,413$7.71$26,314.2399,269View SEC Filing Icon  
1/25/2021Grand Pharmaceutical & H ChinaMajor ShareholderBuy4,067,037$5.45$22,165,351.65View SEC Filing Icon  
11/20/2020Alpha Holdings, Inc.DirectorSell80,000$4.92$393,600.001,350,001View SEC Filing Icon  
11/18/2020Alpha Holdings, Inc.DirectorSell10,999$5.24$57,634.761,480,001View SEC Filing Icon  
11/16/2020Alpha Holdings, Inc.DirectorSell40,000$5.41$216,400.00View SEC Filing Icon  
11/2/2020Daniel J O'connorCEOSell3,280$3.79$12,431.20102,682View SEC Filing Icon  
8/19/2020Grand Pharmaceutical & H ChinaMajor ShareholderBuy2,398,800$3.25$7,796,100.00View SEC Filing Icon  
7/31/2020Daniel J O'connorCEOSell3,133$4.20$13,158.60105,962View SEC Filing Icon  
4/30/2020Daniel J O'connorCEOSell3,075$1.79$5,504.2562,986View SEC Filing Icon  
1/31/2020Daniel J O'connorCEOSell2,654$1.96$5,201.8466,061View SEC Filing Icon  
1/16/2020Sara BonsteinCFOSell1,351$2.08$2,810.0841,389View SEC Filing Icon  
10/31/2019Daniel J O'connorCEOSell2,128$2.16$4,596.4868,715View SEC Filing Icon  
10/16/2019Sara BonsteinCFOSell1,111$2.01$2,233.1142,740View SEC Filing Icon  
7/16/2019Alpha Holdings, Inc.DirectorBuy90,000$2.30$207,000.00View SEC Filing Icon  
5/22/2019Alpha Holdings, Inc.DirectorBuy491,000$3.14$1,541,740.0010,491,000View SEC Filing Icon  
11/20/2018James M DemesaDirectorBuy8,500$0.82$6,970.0014,001View SEC Filing Icon  
11/7/2018Daniel J O'connorCEOBuy10,000$0.91$9,100.0026,667View SEC Filing Icon  
11/7/2018James M DemesaDirectorBuy1,500$0.91$1,365.0014,001View SEC Filing Icon  
7/5/2018Avtar S DhillonDirectorSell37,575$1.39$52,229.25181,002View SEC Filing Icon  
7/5/2018Richard B SlanskyCFOSell84,984$1.39$118,127.76255,000View SEC Filing Icon  
6/29/2018Punit DhillonDirectorSell5,401$1.38$7,453.38355,702View SEC Filing Icon  
6/29/2018Richard B SlanskyCFOSell2,420$1.38$3,339.60255,000View SEC Filing Icon  
6/27/2018Punit DhillonDirectorSell17,480$1.37$23,947.60355,702View SEC Filing Icon  
6/27/2018Richard B SlanskyCFOSell7,832$1.37$10,729.84255,000View SEC Filing Icon  
6/25/2018Punit DhillonDirectorSell1,021$1.41$1,439.61355,702View SEC Filing Icon  
6/25/2018Richard B SlanskyCFOSell458$1.41$645.78255,000View SEC Filing Icon  
6/22/2018Punit DhillonDirectorSell14,976$1.42$21,265.92355,702View SEC Filing Icon  
6/22/2018Richard B SlanskyCFOSell6,710$1.42$9,528.20255,000View SEC Filing Icon  
6/20/2018Punit DhillonDirectorSell55,585$1.42$78,930.70355,702View SEC Filing Icon  
6/20/2018Richard B SlanskyCFOSell24,906$1.42$35,366.52255,000View SEC Filing Icon  
6/18/2018Punit DhillonDirectorSell28,145$1.39$39,121.55355,702View SEC Filing Icon  
6/18/2018Richard B SlanskyCFOSell12,613$1.39$17,532.07255,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for OncoSec Medical (NASDAQ:ONCS)

4.15% of OncoSec Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

OncoSec Medical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/6/2021Sigma Planning Corp14,502$69K0.0%-55.8%0.039%Search for SEC Filing on Google Icon
2/16/2021One68 Global Capital LLC22,261$0.14M0.3%N/A0.080%Search for SEC Filing on Google Icon
2/16/2021Price T Rowe Associates Inc. MD11,400$74K0.0%-33.2%0.041%Search for SEC Filing on Google Icon
2/16/2021Avidity Partners Management LP1,952,000$12.59M0.4%N/A6.974%Search for SEC Filing on Google Icon
2/16/2021ExodusPoint Capital Management LP18,854$0.12M0.0%N/A0.067%Search for SEC Filing on Google Icon
2/12/2021Sandbox Financial Partners LLC75,000$0.48M0.4%N/A0.268%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp27,310$0.18M0.0%+94.9%0.098%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC318,906$2.06M0.0%-20.8%1.139%Search for SEC Filing on Google Icon
2/9/2021Sigma Planning Corp32,802$0.21M0.0%-26.0%0.117%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.60,526$0.39M0.0%+109.1%0.216%Search for SEC Filing on Google Icon
1/30/2021Salzhauer Michael27,303$0.18M0.1%-15.5%0.098%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC10,167$34K0.0%N/A0.036%Search for SEC Filing on Google Icon
11/19/2020Schonfeld Strategic Advisors LLC27,900$95K0.0%N/A0.100%Search for SEC Filing on Google Icon
11/17/2020Schonfeld Strategic Advisors LLC27,900$94K0.0%N/A0.101%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.28,941$98K0.0%-45.7%0.105%Search for SEC Filing on Google Icon
11/3/2020Sigma Planning Corp44,302$0.15M0.0%-8.3%0.160%Search for SEC Filing on Google Icon
8/10/2020D.A. Davidson & CO.118,500$0.24M0.0%+74.9%0.515%Search for SEC Filing on Google Icon
7/31/2020Sigma Planning Corp48,302$99K0.0%+75.6%0.210%Search for SEC Filing on Google Icon
5/1/2020Sigma Planning Corp27,502$35K0.0%N/A0.121%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC198,519$0.36M0.0%+116.5%1.853%Search for SEC Filing on Google Icon
2/10/2020Salzhauer Michael32,303$58K0.0%+127.5%0.302%Search for SEC Filing on Google Icon
11/6/2019Salzhauer Michael14,200$28K0.0%N/A0.133%Search for SEC Filing on Google Icon
11/5/2019D.A. Davidson & CO.24,000$47K0.0%N/A0.225%Search for SEC Filing on Google Icon
8/14/2019Citadel Advisors LLC13,073$33K0.0%N/A0.123%Search for SEC Filing on Google Icon
8/14/2019Worth Venture Partners LLC39,241$99K0.1%N/A0.370%Search for SEC Filing on Google Icon
8/14/2019Vanguard Group Inc.174,640$0.44M0.0%-81.3%1.645%Search for SEC Filing on Google Icon
8/14/2019Private Advisor Group LLC10,500$27K0.0%N/A0.099%Search for SEC Filing on Google Icon
8/13/2019BlackRock Inc.32,568$82K0.0%-93.2%0.307%Search for SEC Filing on Google Icon
8/13/2019Northern Trust Corp11,441$29K0.0%-90.0%0.108%Search for SEC Filing on Google Icon
8/7/2019JPMorgan Chase & Co.18,085$46K0.0%N/A0.170%Search for SEC Filing on Google Icon
2/15/2019Millennium Management LLC40,051$26K0.0%-43.0%0.062%Search for SEC Filing on Google Icon
2/13/2019Geode Capital Management LLC388,688$0.25M0.0%+72.5%0.603%Search for SEC Filing on Google Icon
2/12/2019Northern Trust Corp114,921$73K0.0%+33.6%0.178%Search for SEC Filing on Google Icon
2/11/2019Moloney Securities Asset Management LLC50,000$32K0.0%+117.4%0.078%Search for SEC Filing on Google Icon
2/11/2019Bank of New York Mellon Corp100,325$64K0.0%+484.1%0.156%Search for SEC Filing on Google Icon
2/8/2019BlackRock Inc.485,983$0.31M0.0%+98.2%0.753%Search for SEC Filing on Google Icon
11/15/2018Nexthera Capital LP1,388,824$1.94M0.4%-46.9%2.345%Search for SEC Filing on Google Icon
11/15/2018Point72 Asset Management L.P.1,825,985$2.56M0.0%-17.6%3.083%Search for SEC Filing on Google Icon
9/17/2018683 Capital Management LLC300,000$0.41M0.0%N/A0.573%Search for SEC Filing on Google Icon
8/15/2018Millennium Management LLC1,195,315$1.65M0.0%+19.5%2.283%Search for SEC Filing on Google Icon
8/15/2018Nexthera Capital LP2,614,297$3.61M0.6%+26.6%4.994%Search for SEC Filing on Google Icon
8/14/2018Point72 Asset Management L.P.2,215,000$3.06M0.0%-31.1%4.231%Search for SEC Filing on Google Icon
8/14/2018DRW Securities LLC180,000$0.25M0.0%+157.1%0.344%Search for SEC Filing on Google Icon
8/9/2018BlackRock Inc.238,940$0.33M0.0%+1,303.5%0.456%Search for SEC Filing on Google Icon
5/16/2018Millennium Management LLC1,000,576$1.88M0.0%+2,073.8%1.944%Search for SEC Filing on Google Icon
5/16/2018Nexthera Capital LP2,064,297$3.88M0.6%N/A4.010%Search for SEC Filing on Google Icon
5/15/2018Point72 Asset Management L.P.3,215,000$6.04M0.0%+47.5%6.245%Search for SEC Filing on Google Icon
5/15/2018venBio Select Advisor LLC4,007,696$7.53M0.4%N/A7.785%Search for SEC Filing on Google Icon
5/15/2018Sofinnova Ventures Inc66,965$0.13M0.0%N/A0.130%Search for SEC Filing on Google Icon
5/14/2018DRW Securities LLC70,000$0.13M0.0%N/A0.136%Search for SEC Filing on Google Icon
5/14/2018Commonwealth Equity Services LLC76,510$0.14M0.0%+97.6%0.149%Search for SEC Filing on Google Icon
2/16/2018J. Goldman & Co LP100,000$0.16M0.0%N/A0.233%Search for SEC Filing on Google Icon
2/15/2018Sabby Management LLC153,137$0.25M0.0%-84.8%0.357%Search for SEC Filing on Google Icon
2/14/2018Deutsche Bank AG160,759$0.26M0.0%N/A0.374%Search for SEC Filing on Google Icon
2/13/2018Renaissance Technologies LLC167,093$0.27M0.0%N/A0.389%Search for SEC Filing on Google Icon
2/13/2018MYDA Advisors LLC89,000$0.15M0.1%N/A0.207%Search for SEC Filing on Google Icon
5/15/2017Sabby Management LLC975,839$1.26M0.1%-16.9%4.676%Search for SEC Filing on Google Icon
2/13/2017Renaissance Technologies LLC95,000$0.12M0.0%-39.6%0.481%Search for SEC Filing on Google Icon
8/15/2016Sabby Management LLC608,052$1M0.1%-45.3%3.448%Search for SEC Filing on Google Icon
5/13/2016Sabby Management LLC1,111,348$2.83M0.1%-9.2%6.549%Search for SEC Filing on Google Icon
5/13/2016Renaissance Technologies LLC43,400$0.11M0.0%N/A0.256%Search for SEC Filing on Google Icon
5/13/2016Geode Capital Management LLC57,031$0.15M0.0%No Change0.336%Search for SEC Filing on Google Icon
2/16/2016Ridgeback Capital Investments L.P.1,292,614$3.06M13.2%N/A7.617%Search for SEC Filing on Google Icon
1/13/2016Gierl Augustine Investment Management200$00.0%N/A0.001%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
OncoSec Medical logo
OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 (IL-12) for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in Phase IIb clinical trials (KEYNOTE-695) and advanced or metastatic triple negative breast cancer (TNBC), which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and new DNA-encoded therapeutic candidates and tumor indications to treat deep visceral lesions, such as liver, lung, bladder, pancreatic, and other visceral lesions. It has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate enhanced IL-12 DNA-plasmid; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was founded in 2008 and is headquartered in Pennington, New Jersey.
Read More on OncoSec Medical

Today's Range

Now: $4.02
$4.02
$4.31

50 Day Range

MA: $4.98
$4.09
$5.74

52 Week Range

Now: $4.02
$1.51
$8.16

Volume

204,178 shs

Average Volume

262,578 shs

Market Capitalization

$149.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.64

Who are the company insiders with the largest holdings of OncoSec Medical?

OncoSec Medical's top insider shareholders include:
  1. Alpha Holdings, Inc (Director)
  2. Daniel J O'connor (CEO)
  3. Sara Bonstein (CFO)
  4. Robert J Delaversano (VP)
  5. Grand Pharmaceutical & H China (Major Shareholder)

Who are the major institutional investors of OncoSec Medical?

OncoSec Medical's top institutional shareholders include:
  1. Sigma Planning Corp — 0.04%

Which major investors are selling OncoSec Medical stock?

Within the last quarter, ONCS stock was sold by these institutional investors:
  1. Sigma Planning Corp
During the previous year, company insiders that have sold OncoSec Medical company stock include:
  1. Alpha Holdings, Inc (Director)
  2. Daniel J O'connor (CEO)
  3. Sara Bonstein (CFO)
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel